This inventor holds 1 USPTO granted patent. Top assignee: Howard Hughes Medical Institute. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Mark Bathe: Innovator in Nucleic Acid Nanostructures
Introduction
Mark Bathe is a prominent inventor based in Lincoln, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of immune stimulation through innovative nanostructures. His work is recognized for its potential to advance therapeutic strategies in immunology.
Latest Patents
Mark Bathe holds a patent for a "Nucleic Acid Nanostructure Platform for Programming Immune Stimulation." This patent represents a breakthrough in the design of nanostructures that can effectively modulate immune responses, showcasing his expertise in the intersection of nanotechnology and immunology. He has 1 patent to his name.
Career Highlights
Mark Bathe is affiliated with the Howard Hughes Medical Institute, where he conducts research that bridges the gap between fundamental science and practical applications. His work has garnered attention for its innovative approach to programming immune responses, which could lead to new treatments for various diseases.
Collaborations
Throughout his career, Mark has collaborated with notable colleagues, including Remi Veneziano and Eike-Christian Wamhoff. These partnerships have enriched his research and contributed to the advancement of knowledge in the field.
Conclusion
Mark Bathe is a distinguished inventor whose work in nucleic acid nanostructures is paving the way for new immunological therapies. His contributions to science and technology continue to inspire advancements in the field.